recall
saveAmerisource Health Services LLC recall (Cls II)
January 1, 2025updated 5mo ago
community read0 votes
Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit. — Status: Ongoing
view source ↗Data sources
last refreshed 33m ago
Found something off?
same company · ±60 days · 6
- recallAmerisource Health Services LLC recall (Cls II)Jan 1, 2025
- recallAmerisource Health Services LLC recall (Cls II)Jan 1, 2025
- recallAmerisource Health Services LLC recall (Cls II)Jan 1, 2025
- recallAmerisource Health Services LLC recall (Cls II)Dec 11, 2024
- approvalFINGOLIMOD HYDROCHLORIDE: FINGOLIMOD HYDROCHLORIDE — FDA approvalJan 22, 2025
- recallAmerisource Health Services LLC recall (Cls II)Dec 11, 2024
🐶 often sniffed alongside
top 8- tagApproval708 co-mentions · 354 sources
- tagSmall Molecule348 co-mentions · 348 sources
- companyAurobindo Pharma USA Inc81 co-mentions · 69 sources
- drugALDACTAZIDE60 co-mentions · 31 sources
- druglamotrigine SR38 co-mentions · 38 sources
- drugondansetron hydrochloride ODT29 co-mentions · 29 sources
- drugondansetron ODT29 co-mentions · 29 sources
- drugONDANSETRON29 co-mentions · 29 sources
comments(0)
5-min edit window · permanent after that